New York Business Law Attorneys
Cahill Gambino LLP is a boutique law firm which traces its heritage from the world's premiere law firms.
Each of our lawyers is dedicated and accomplished in their respective fields of practice. Our practice areas include securities regulation, securities, class action, and other commercial litigation, corporate and transactional representation, and general counsel services. Our clients include public and private companies, financial institutions, hedge funds, and emerging enterprises. We deliver value to our clients through our good judgment, practical and effective advice, and responsive senior lawyer attention. We assist our clients in achieving their objectives by providing sophisticated legal advice and unparalleled devotion to client service. We are dedicated to delivering excellence to our clients in all facets of our practice. Call us today at 518.584.1991 to learn how we can help you with your legal situation.
On June 6, 2016, the Delaware Supreme Court affirmed Cahill Gambino LLP‘s multi-million dollar, class action verdict won in the Delaware Court of Chancery. Fox v. CDX Holdings Inc. (f/k/a Caris Life Sciences, Inc.), C.A. No. 8031-VCL, 2015 Del Ch. Lexis 194 (Del Ch. Jul. 28, 2015) aff’d 141 A.3d 1037 (Del. 2016). Cahill Gambino won the verdict on behalf of the former option holders of Caris Life Sciences, Inc. (“Caris”) whose options were eliminated as part of a forced option repurchase. The verdict and ultimate resolution resulted in a total recovery on behalf of the Option Holders of twenty-four million dollars ($24,000,000). As the option holders were only a small percentage of Caris’ equity ownership, Cahill Gambino had to prove the valuations used by the corporation undervalued the assets at issue by over $200 million. The victory was unusual for not only its size but that it issued from the prominent Delaware Chancery Court. See Matt Levine, "Judge Won’t Let Medical Company Sell Itself Short," Bloomberg, (July 29, 2015).Fox v. CDX Holdings Inc., f.k.a. Caris Life Sciences, Inc.